Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for healthcare industry professionals · Thursday, January 30, 2025 · 781,686,501 Articles · 3+ Million Readers

Veterinary Vaccines Market to Cross $14.5 Billion by 2032, Driven by Rising Pet Ownership & Zoonotic Disease Prevention

Veterinary Vaccines Market

Veterinary Vaccines Market

Veterinary Vaccines Market Set for Steady Growth with Rising Demand for Animal Health Solutions

AUSTIN, TX, UNITED STATES, January 29, 2025 /EINPresswire.com/ -- According to Research by SNS Insider, The global veterinary vaccines market size was valued at USD 8.5 billion in 2023, is projected to reach USD 14.5 billion by 2032, growing at a CAGR of 6% during the forecast period of 2024-2032.

Rising Demand for Veterinary Vaccines Driven by Animal Health Awareness and Technological Advancements

The Veterinary vaccine market is responsible for developing and distributing vaccines that protect animals from diseases and is an important component of animal health management, including domestic animals (such as pets), livestock, and wildlife. Increasing recognition of animal health and an upsurge in zoonotic diseases are major factors influencing the market demand. The increasing number of pets in developed countries and better livestock health in developing countries also drive demand in the market. In addition, high disease prevalence,  such as foot-and-mouth and rabies, increases the vaccine demand. The market growth is also attributed to advancements in vaccine technology and a greater emphasis on preventive care. R&D is still firm, constantly innovating against new health threats. Asia-Pacific is also showing significant growth due to livestock farming and increasing incomes. The market is still evolving despite regulatory challenges.

Get a Free Sample Report of Veterinary Vaccines Market @ https://www.snsinsider.com/sample-request/4555

Key Players in Veterinary Vaccines Market
• Zoetis Inc.
• Boehringer Ingelheim
• Merck Animal Health
• Elanco Animal Health
• Ceva Santé Animale
• Virbac
• Phibro Animal Health Corporation
• Vetoquinol
• HIPRA
• Biogenesis Bago
• Neogen Corporation
• Idexx Laboratories
• Indian Immunologicals Ltd.
• Hester Biosciences
• Dechra Pharmaceuticals

Segmentation Analysis
By Type
Live attenuated vaccines are highly effective and provide long-lasting immunity, therefore play an important role in the veterinary vaccine market. These vaccines are made up of weakened forms of pathogens that provide a potent immune response without directly causing the disease. They work especially well against viral infections, providing fast and lasting protection, and apply to both companion and livestock animals. Live attenuated vaccines simulate natural infection to promote strong cellular and humoral immunity in animals. Moreover, they tend to need fewer booster doses than other types of vaccines, making them cheaper and more feasible for large-scale use. With expertise in multiple animal species and diseases, they are particularly effective in controlling large-scale outbreaks and maintaining herds.

By Application
The Companion Animals segment is a major segment holding a prominent part of the veterinary vaccine market owing to increasing pet ownership and awareness regarding pet health. More than humans, dogs, cats, and other companion animals need vaccines to prevent zoonotic diseases like rabies and ensure overall animal welfare. As pets become more evenly seen as members of their families, owners are spending more money on preventive health, including vaccinations. Another factor contributing to this market growth is the increasing incidence of infectious diseases in companion animals, driving the need for effective vaccines. Moreover, the segment is witnessing growth owing to the advancement in veterinary care and the availability of specific immunizations designed for pet facilities. The growth of this segment is also aided by veterinary clinics, animal shelters, and pet care providers encouraging routine immunization programs.

Need any customization research on Veterinary Vaccines Market, Enquire Now @ https://www.snsinsider.com/enquiry/4555

Veterinary Vaccines Market Segmentation

By Type:
• Live Attenuated Vaccines
• Inactivated Vaccines
• Subunit, Recombinant, and Conjugate Vaccines
• DNA and mRNA Vaccines

By Application:
• Companion Animals
• Livestock
• Wildlife

Regional Analysis
In 2023, North America dominated the veterinary vaccines market, with the United States and Canada being the largest contributors. This can be attributed to the large pet population, the growing adoption of advanced veterinary practices in the region, and the strong investments in veterinary research and development in this region. Moreover,  the existence of established veterinary infrastructure and high cognizance regarding animal health have collaborated further segments of the market in this region. Moreover, constant advancements in the field of veterinary technology in the region enable the use of advanced vaccines for the prevention of animal diseases and their implications on public health.

Asia-Pacific region is expected to emerge as the fastest-growing regional market for veterinary vaccines,  where the livestock population is growing at a rapid pace along with a rise in pet ownership in countries such as China, India, and Japan. With rising disposable income and awareness regarding animal health, the healthcare infrastructure in these emerging markets is improving, driving the increased demand for veterinary vaccines. So too, the growing governmental and private investments in veterinary research and development around the region are set to play their part in a healthy growth story for the market in the years to come.

Recent Developments
• In May 2024, MSD Animal Health, a division of Merck & Co., Inc., headquartered in Rahway, New Jersey, USA, secured marketing authorization from the European Commission for its INNOVAX-ND-H5 vaccine, developed specifically for chickens.
• In June 2024, HIPRA introduced its innovative DIVENCE vaccine range at the World Buiatrics Congress in Mexico. This new lineup is designed to enhance the prevention of significant viral diseases affecting cattle.

Buy Full Research Report on Veterinary Vaccines Market 2024-2032 @ https://www.snsinsider.com/checkout/4555

Table of Contents – Major Key Points
1. Introduction
2. Executive Summary
3. Research Methodology
4. Market Dynamics Impact Analysis
5. Statistical Insights and Trends Reporting
6. Competitive Landscape
7. Veterinary Vaccines Market by Type
8. Veterinary Vaccines Market by Application
9. Regional Analysis
10. Company Profiles
11. Use Cases and Best Practices
12. Conclusion

Speak with Our Expert Analyst Today to Gain Deeper Insights @ https://www.snsinsider.com/request-analyst/4555

About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

Browse More Insights:
Veterinary Vaccine Adjuvants Market Report
Companion Animal Vaccines Market Report

Akash Anand
SNS Insider Pvt. Ltd
415-230-0044
email us here
Visit us on social media:
Facebook
X
LinkedIn
Instagram

Powered by EIN Presswire

Distribution channels: Healthcare & Pharmaceuticals Industry

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Submit your press release